Frank Löhr

Dr. Frank Löhr

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2004 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
CKChristian Klammt
Christian Klammt
FLFrank Löhr
Frank Löhr
BSBirgit Schäfer
Birgit Schäfer
WHWinfried Haase
Winfried Haase
VDVolker Dötsch
Volker Dötsch
FBFrank Bernhard
Frank Bernhard
We demonstrate the high level expression of integral membrane proteins (IMPs) in a cell‐free coupled transcription/translation system using a modified Escherichia coli S30 extract preparation and an optimized protocol. The expression of the E. coli small multidrug transporters EmrE and SugE containing four transmembrane segments (TMS), the multidrug transporter TehA with 10 putative TMS, and the cysteine transporter YfiK with six putative TMS, were analysed. All IMPs were produced at high levels yielding up to 2.7 mg of protein per mL of reaction volume. Whilst the vast majority of the synthesized IMPs were precipitated in the reaction mixture, the expression of a fluorescent EmrE‐sgGFP fusion construct showed evidence that a small part of the synthesized protein ‘remained soluble and this amount could be significantly increased by the addition of E. coli lipids into the cell‐free reaction. Alternatively, the majority of the precipitated IMPs could be solubilized in detergent micelles, and modifications to the solubilization procedures yielded proteins that were almost pure. The folding induced by formation of the proposed α‐helical secondary structures of the IMPs after solubilization in various micelles was monitored by CD spectroscopy. Furthermore, the reconstitution of EmrE, SugE and TehA into proteoliposomes was demonstrated by freeze‐fracture electron microscopy, and the function of EmrE was additionally analysed by the specific transport of ethidium. The cell‐free expression technique allowed efficient amino acid specific labeling of the IMPs with 15N isotopes, and the recording of solution NMR spectra of the solubilized EmrE, SugE and YfiK proteins further indicated a correctly folded conformation of the proteins.

13 May 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ADAnja Dölle
Anja Dölle
BABikash Adhikari
Bikash Adhikari
AKAndreas Krämer
Andreas Krämer
JWJanik Weckesser
Janik Weckesser
NBNicola Berner
Nicola Berner
SKStefan Knapp
Stefan Knapp

Verified
Journal Article
Open access
PDF file
ALAnna Lopata
Anna Lopata
AKAndreas Kniss
Andreas Kniss
FLFrank Löhr
Frank Löhr
VRVladimir Rogov
Vladimir Rogov
VDVolker Dötsch
Volker Dötsch
In this review, we focus on the ubiquitination process within the endoplasmic reticulum associated protein degradation (ERAD) pathway. Approximately one third of all synthesized proteins in a cell are channeled into the endoplasmic reticulum (ER) lumen or are incorporated into the ER membrane. Since all newly synthesized proteins enter the ER in an unfolded manner, folding must occur within the ER lumen or co-translationally, rendering misfolding events a serious threat. To prevent the accumulation of misfolded protein in the ER, proteins that fail the quality control undergo retrotranslocation into the cytosol where they proceed with ubiquitination and degradation. The wide variety of misfolded targets requires on the one hand a promiscuity of the ubiquitination process and on the other hand a fast and highly processive mechanism. We present the various ERAD components involved in the ubiquitination process including the different E2 conjugating enzymes, E3 ligases, and E4 factors. The resulting K48-linked and K11-linked ubiquitin chains do not only represent a signal for degradation by the proteasome but are also recognized by the AAA+ ATPase Cdc48 and get in the process of retrotranslocation modified by enzymes bound to Cdc48. Lastly we discuss the conformations adopted in particular by K48-linked ubiquitin chains and their importance for degradation.

1 April 2003 in Journal of Biomolecular NMR
Verified
Journal Article
Closed access
PDF file
FLFrank Löhr
Frank Löhr
VKVicky Katsemi
Vicky Katsemi
JHJudith Hartleib
Judith Hartleib
UGUlrich Günther
Ulrich Günther
HRHeinz Rüterjans
Heinz Rüterjans

20 January 2007 in Journal of Biomolecular NMR
Verified
Journal Article
Closed access
PDF file
FLFrank Löhr
Frank Löhr
RHRobert Hänsel
Robert Hänsel
VRVladimir Rogov
Vladimir Rogov
VDVolker Dötsch
Volker Dötsch

3 December 2020 in Biomolecular NMR Assignments
Verified
Journal Article
Open access
PDF file
SKSophie Marianne Korn
Sophie Marianne Korn
RLRoderick Lambertz
Roderick Lambertz
BFBoris Fürtig
Boris Fürtig
MHMartin Hengesbach
Martin Hengesbach
FLFrank Löhr
Frank Löhr
ASAndreas Schlundt
Andreas Schlundt
The current outbreak of the highly infectious COVID-19 respiratory disease is caused by the novel coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). To fight the pandemic, the search for promising viral drug targets has become a cross-border common goal of the international biomedical research community. Within the international Covid19-NMR consortium, scientists support drug development against SARS-CoV-2 by providing publicly available NMR data on viral proteins and RNAs. The coronavirus nucleocapsid protein (N protein) is an RNA-binding protein involved in viral transcription and replication. Its primary function is the packaging of the viral RNA genome. The highly conserved architecture of the coronavirus N protein consists of an N-terminal RNA-binding domain (NTD), followed by an intrinsically disordered Serine/Arginine (SR)-rich linker and a C-terminal dimerization domain (CTD). Besides its involvement in oligomerization, the CTD of the N protein (N-CTD) is also able to bind to nucleic acids by itself, independent of the NTD. Here, we report the near-complete NMR backbone chemical shift assignments of the SARS-CoV-2 N-CTD to provide the basis for downstream applications, in particular site-resolved drug binding studies.